|
2025
|
P/S
|
Providing insurance information to patients and healthcare professionals in the field of health i... |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer |
|
|
Invention
|
Methods of treating acute leukemias with a menin inhibitor in a combination therapy. Provided her... |
|
|
Invention
|
Methods of improving glycemic control with a menin inhibitor. Provided herein are methods of impr... |
|
|
Invention
|
Methods for treating hematological malignancies and ewing's sarcoma.
The present disclosure prov... |
|
2024
|
Invention
|
Methods of treating kit positive cancers with a menin inhibitor. Provided herein are methods of t... |
|
|
Invention
|
Crystalline forms of a menin inhibitor. Described herein are crystalline forms of (S)-4-methyl-5-... |
|
|
Invention
|
Pharmaceutical compositions comprising a menin inhibitor.
Described herein are crystalline forms... |
|
|
Invention
|
Pharmaceutical compositions comprising a menin inhibitor. Provided herein are crystalline forms o... |
|
|
Invention
|
Solid forms of a macrocyclic farnesyltransferase inhibitor and formulations thereof, and methods ... |
|
|
Invention
|
Farnesyltransferase inhibitors for treatment of kras-dependent cancers. Provided herein are metho... |
|
|
Invention
|
Methods of treating squamous cell carcinoma with a farnesyltransferase inhibitor and a pi3k inhib... |
|
|
Invention
|
Treatment of non-small cell lung cancer with a combination of 3-amino-3-(1-methyl-1h-imidazol-5-y... |
|
|
Invention
|
Macrocyclic compounds and compositions, and methods of preparing and using the same.
The present... |
|
|
P/S
|
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharm... |
|
|
P/S
|
Pharmaceuticals for human use, namely, pharmaceutical
preparations for treatment of cancer; phar... |
|
2023
|
Invention
|
Methods of treating advanced solid tumors. Provided herein are methods of using a compound of For... |
|
|
Invention
|
A farnesyltransferase inhibitor (fti) and an egfr-tki for use in treating non-small cell lung can... |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer. Providing information in the fields of cance... |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer Providing information in the fields of cancer... |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer. Providing funds for research in the fields o... |
|
|
Invention
|
Methods of treating acute leukemia. NPM1KMT2AKMT2A) gene, wherein the methods comprise administer... |
|
|
Invention
|
Methods of treating head and neck squamous cell carcinoma.
Provided herein are methods of tipifa... |
|
|
Invention
|
Macrocyclic compounds and compositions, and methods of preparing and using the same. The present ... |
|
|
P/S
|
Providing funds for research of others in the fields of cancer treatment, precision medicine, and... |
|
|
Invention
|
Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors.
The present in... |
|
|
Invention
|
Methods of treating head and neck squamous cell carcinoma. Provided herein are methods of tipifar... |
|
|
Invention
|
Treatment of cancer with menin inhibitors and immuno-oncology agents.
The present disclosure rel... |
|
|
Invention
|
Treatment of cancer with menin inhibitors and immuno-oncology agents. The present disclosure rela... |
|
|
Invention
|
Treatment of hematological malignancies with menin inhibitors and p-glycoprotein inhibitors.
The... |
|
|
Invention
|
Treatment of hematological malignancies with menin inhibitors and p-glycoprotein inhibitors. The ... |
|
2022
|
Invention
|
Macrocyclic compounds having farnesyltransferase inhibitory activity. The present invention relat... |
|
|
Invention
|
Methods of treating cancer patients with farnesyltransferase inhibitors.
The present invention r... |
|
2021
|
Invention
|
Treatment of hematological malignancies with inhibitors of menin.
The present disclosure provide... |
|
|
Invention
|
Treatment of hematological malignancies with inhibitors of menin. The present disclosure provides... |
|
|
Invention
|
Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors. The present inv... |
|
2020
|
Invention
|
Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors.
The present inve... |
|
|
Invention
|
Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors. The present inven... |
|
|
Invention
|
Methods of treating cancer with farnesyltransferase inhibitors.
The present invention relates to... |
|
|
Invention
|
Methods of treating cancer with farnesyltransferase inhibitors. The present invention relates to ... |
|
|
Invention
|
Methods of treating cancer patients with farnesyltransferase inhibitors. The present invention re... |
|
2019
|
Invention
|
Therapies for squamous cell carcinomas.
The present invention relates to the field of cancer the... |
|
|
Invention
|
Therapies for squamous cell carcinomas. The present invention relates to the field of cancer ther... |
|
|
Invention
|
Treatment of adenocarcinomas with mapk pathway inhibitors. The present disclosure provides method... |
|
|
Invention
|
Synthesis of tipifarnib. Provided herein are methods of preparing a desired enantiomer 6-[amino(4... |
